Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Fanconi Anemia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Fanconi Anemia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Fanconi Anemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
88 pages
Hepatitis C Virus Envelope Protein E2 - Pipeline Review, H2 2020
US$ 3,500.00
... Hepatitis C Virus Envelope Protein E2 targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
November 2020
34 pages
Heterozygous familial hypercholesterolemia (heFH) - Pipeline Review, H2 2020
US$ 2,000.00
... The Heterozygous familial hypercholesterolemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Heterozygous familial hypercholesterolemia (heFH) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
116 pages
Hypereosinophilic Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Hypereosinophilic Syndrome (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hypereosinophilic Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
116 pages
Nephrotic Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Nephrotic Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2020
62 pages
Progressive Multifocal Leukoencephalopathy - Pipeline Review, H2 2020
US$ 2,000.00
... . The Progressive Multifocal Leukoencephalopathy (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Progressive Multifocal Leukoencephalopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
45 pages
Spinocerebellar Ataxia (SCA) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Spinocerebellar Ataxia (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Spinocerebellar Ataxia (SCA) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
114 pages
Tularaemia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Tularaemia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Tularaemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
46 pages
Fibroblast Growth Factor 2 - Pipeline Review, H2 2020
US$ 3,500.00
Fibroblast Growth Factor 2 - Pipeline Review, H2 2020 SUMMARY Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) pipeline Target constitutes close...
November 2020
61 pages
Insulin Like Growth Factor I - Pipeline Review, H2 2020
US$ 3,500.00
Insulin Like Growth Factor I - Pipeline Review, H2 2020 SUMMARY Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Insulin-like growth factor 1 (IGF-1) also called somat...
November 2020
52 pages
Insulin Like Growth Factor II - Pipeline Review, H2 2020
US$ 3,500.00
Insulin Like Growth Factor II - Pipeline Review, H2 2020 SUMMARY According to the recently published report 'Insulin Like Growth Factor II - Pipeline Review, H2 2020'; Insulin Like Growth Factor II...
November 2020
48 pages
Cyclin Dependent Kinase 2 - Pipeline Review, H2 2020
US$ 3,500.00
Cyclin Dependent Kinase 2 - Pipeline Review, H2 2020 SUMMARY Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) - Cyclin-dependent kinase 2 is a...
November 2020
95 pages
Glucagon Like Peptide 2 Receptor - Pipeline Review, H2 2020
US$ 3,500.00
Glucagon Like Peptide 2 Receptor - Pipeline Review, H2 2020 SUMMARY Glucagon Like Peptide 2 Receptor (GLP2R) - Glucagon-like peptide 2 receptor (GLP-2R) is a protein encoded by the GLP2R gene. GLP2R...
November 2020
67 pages
Glucokinase - Pipeline Review, H2 2020
US$ 3,500.00
Glucokinase - Pipeline Review, H2 2020 SUMMARY Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) pipeline Target constitutes close to 14 molecules. Out of which approximately 12 molecu...
November 2020
74 pages
Protein Kinase C Epsilon Type - Pipeline Review, H2 2020
US$ 3,500.00
Protein Kinase C Epsilon Type - Pipeline Review, H2 2020 SUMMARY Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Protein kinase C (PKC) is an enzyme belonging to a family of...
November 2020
60 pages
Transthyretin - Pipeline Review, H2 2020
US$ 3,500.00
Transthyretin - Pipeline Review, H2 2020 SUMMARY According to the recently published report 'Transthyretin - Pipeline Review, H2 2020'; Transthyretin (ATTR or Prealbumin or TBPA or TTR) pipeline Tar...
November 2020
116 pages
Gingivitis - Pipeline Review, H2 2020
US$ 2,000.00
Gingivitis - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gingivitis - Pipeline Review, H2 2020, provides an overview of the G...
November 2020
40 pages
Acute Lymphocytic Leukemia - Pipeline Review, H2 2020
US$ 2,500.00
Acute Lymphocytic Leukemia - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Lymphocytic Leukemia - Pipeline Review, H2 202...
November 2020
1809 pages
Adrenoleukodystrophy - Pipeline Review, H2 2020
US$ 2,000.00
Adrenoleukodystrophy - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Adrenoleukodystrophy - Pipeline Review, H2 2020, provides...
November 2020
104 pages
Catenin Beta 1 - Pipeline Review, H2 2020
US$ 3,500.00
Catenin Beta 1 - Pipeline Review, H2 2020 SUMMARY Catenin Beta 1 (Beta Catenin or CTNNB1) pipeline Target constitutes close to 14 molecules. Out of which approximately 12 molecules are developed by...
November 2020
69 pages
Chronic Myelocytic Leukemia - Pipeline Review, H2 2020
US$ 2,000.00
Chronic Myelocytic Leukemia - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Myelocytic Leukemia - Pipeline Review, H2 2...
November 2020
693 pages
Prostate Cancer - Pipeline Review, H2 2020
US$ 2,500.00
Prostate Cancer - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer - Pipeline Review, H2 2020, provides an overvie...
November 2020
3323 pages
Soluble Guanylate Cyclase - Pipeline Review, H2 2020
US$ 3,500.00
Soluble Guanylate Cyclase - Pipeline Review, H2 2020 SUMMARY Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) pipeline Target constitutes close to 29 molecules. Out of which approximately 26 molecules...
November 2020
108 pages
Head And Neck Cancer - Pipeline Review, H2 2020
US$ 2,000.00
... . The Head And Neck Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Head And Neck Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development ...
October 2020
3419 pages
Gastric Cancer - Pipeline Review, H2 2020
US$ 2,500.00
... releases. The Gastric Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Gastric Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
2657 pages
Asthma - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Asthma (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Asthma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
811 pages
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Chronic Obstructive Pulmonary Disease (COPD) (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Chronic Obstructive Pulmonary Disease (COPD) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
576 pages
Osteoporosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Osteoporosis (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteoporosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
375 pages
Allergic Rhinitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Allergic Rhinitis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Allergic Rhinitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
204 pages
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2020
US$ 2,000.00
... Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Chronic Kidney Disease (Chronic Renal Failure) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
326 pages
Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Idiopathic Pulmonary Fibrosis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Idiopathic Pulmonary Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
539 pages
Acne Vulgaris - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Acne Vulgaris (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Acne Vulgaris and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
217 pages
Endometriosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Endometriosis (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Endometriosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
156 pages
Osteoarthritis Pain - Pipeline Review, H2 2020
US$ 2,000.00
... . The Osteoarthritis Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Osteoarthritis Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
233 pages
Premature Ejaculation - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Premature Ejaculation (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Premature Ejaculation and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
42 pages
Cystic Fibrosis - Pipeline Review, H2 2020
US$ 2,500.00
... releases. The Cystic Fibrosis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Cystic Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
550 pages
Ulcerative Colitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Ulcerative Colitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Ulcerative Colitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
779 pages
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Adrenocortical Carcinoma (Adrenal Cortex Cancer) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Adrenocortical Carcinoma (Adrenal Cortex Cancer) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
204 pages
Oropharyngeal Cancer - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Oropharyngeal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Oropharyngeal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
724 pages
Chronic Urticaria Or Hives - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Chronic Urticaria Or Hives (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Chronic Urticaria Or Hives and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
152 pages
Sickle Cell Disease - Pipeline Review, H2 2020
US$ 2,000.00
... . The Sickle Cell Disease (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Sickle Cell Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
308 pages
Vitiligo - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Vitiligo (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Vitiligo and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
158 pages
Post Menopausal Osteoporosis - Pipeline Review, H2 2020
US$ 2,000.00
... . The Post Menopausal Osteoporosis (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Post Menopausal Osteoporosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
131 pages
Allergic Conjunctivitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Allergic Conjunctivitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Allergic Conjunctivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
113 pages
Angina (Angina Pectoris) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Angina (Angina Pectoris) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Angina (Angina Pectoris) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
89 pages
